Advancements of stem-cell therapy for type 1 diabetes mellitus

19 4 2007 8 Chinese Bulletin of Life Sciences Vol. 19, No. 4 Aug., 2007 1004-0374(2007)04-0401-08 1 ( 121001) 1 β β 1 1 R58.71; Q813 A Advancements of stem-cell therapy for type 1 diabetes mellitus LI Hongdan, WEI Jia, MU Changzheng* (Liaoning Medical College, Jinzhou 121001, China ) Abstract: Type 1 diabetes is characterized by the selective destruction of pancreatic β-cells caused by an autoimmune attack. Restoration of damaged β-cells by transplantation from exogenous sources or by endocrine pancreas regeneration would be ideal therapeutic options. Stem cells of both embryonic and adult origin offer some interesting alternatives, taking into account the latest advances indicating that these cells could be the potential building blocks from which insulin secreting cells could be obtained in vitro under appropriate culture conditions. Although it has been reported that insulin-producing cells derived from stem cells have been shown to reverse experimentally induced diabetes in animal models, several concerns need to be solved before finding a definite medical application. These refer mainly to the obtainment of a cell population as similar as possible to pancreatic β-cells, and to the problems related with the immune compatibility and tumor formation. This review will describe the different approaches that have been used to obtain insulin-producing cells from embryonic and adult stem cells, the effect of cell transplantation for treating type 1 diabetes mellitus and analyze the main problems of therapy with these stem cells and the possible solving methods. Key words: stem cell; induced differentiation; insulin secreting cells; type 1 diabetes mellitus; biological therapy 1 2 WHO1997 1.35 2007-02-06 2007-04-05 (1981 ) (1962 ) * E-mail muchangzheng@yahoo.com.cn

402 19 2025 3 2000 Bonner- Weir [1] 2010 3.5 1 1 1 1 T T T NOD 1 T NOD [2] Mathis [3] T (antigen presenting cells APCs) (dendritic cell) APCs MHC T APCs β T MHC Pβ 2 β 10 [4] Shapiro [5] 7 1 1 4 2 [6] (Edmonton protocol) (ESC) (ASC) ( 1) [7] 2.1 Lumelsky [8] β 1 2 1/50 Glut2 IAPP ( ) 12 d Assady [9] (hes) hes β β ( Glut2) 2002 Hori [10] LY294002 ( 3 )

4 1 403 1 β [7] DNA Rajagopal [11] ES β β Hansson [12] os25 ( β Sox2 ) C C Vacap [13] ESD3 STZ C D Amour [14] C Fujikawa [15] Lumelsky [8] 30 d NOD/SCID 2.2 2.2.1 β Chen [16] Wistar 10 mmol/l 1 mmol/l β DMEM 24 h 10 mmol/l 1 mmol/l β 10 h mrna STZ

404 19 Oh [17] 1% DMSO 3 d 10% FBS 7 d mrna 186 ng/ml 80% C STZ NOD/SCID Tang [18] Balb/c 10% FCS RPMI-1640 2 4 (5.5 mmol/l) (5%) 10 mmol/l RPMI-1640 7 d 10 nmol/l exendin-4 5 7 d C mrna ins-1 ins-2 Glut-2 GK pdx-1 Moriscot [19] pdx-1 β exendin-4 β [20] [21] bfgf HGF LY294002 β Choi [22] Petersen [23] 1 h Lu [24] Lee [25] Kim [26] C C β 20 50 ( ) 1 Ianus [27] 1 2 β Y β Hess [28] STZ (GFP) 17 d 42 d 75% 85% 42 d 0% 50% c-kit c-kit 2.2.2 (UCB) 2007 1 2 [29-30] Ende [29] 2 1

4 1 405 [30] Sun [31] SSEA-4 OCT-4 DMEM/F12 10 mmol/l 20 nmol/l 100 mol/l 1 g/ml 25 g/ml 30 mol/l 50 g/ml 5 g/ml B27 (1 50) 15% FBS 24 h DMEM DMEM/F12 5 7 d C 2.2.3 Zhang [32] 16 nestin α β exendin-4 nestin CD44 CD90 CD147 CD34 CD38 CD45 CD71 CD117 CD133 HLA-DR 2.2.4 4 β α δ γ Bouwens [33] Cossel [34] Dudek [35] Bonner- Weir [1] 2007 Koblas [36] CXCR4 CXCR4 2.2.5 Yang [37] mrna 2.2.6 Timper [38] ( 1)

406 19 1 3 ( ) bfgf exendin-4 (1) (2) RT- PCR C Glut-1 Glut-2 GK IAPP nestin β PDX-1 PAX-6 PAX-4 OCT-4 C C β C C 4 4.1 (1) 1 (2) (3) NO

4 1 407 4.2 Fujikawa [15] 30 d 4.3 4.4 4.5 1 β 5 1 1 [1] Bonner-Weir S, Taneja M, Weir G C. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA, 2000, 97(14): 7999-8004 [2] Bach J F, Mathis D. The NOD mouse. Res Immunol 1997, 148(5): 285-286 [3] Mathis D, Vence L, Benoist C. β-cell death during progression to diabetes. Nature, 2001, 414 (6865): 792-798 [4] Lakey J R T, Warnock G L, Shapiro A M, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant, 1999, 8 (3): 285-292 [5] Shapiro A M J, Lakey J R T, Ryan E A, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New Engl J Med, 2000, 43 (4): 230-238 [6] Ryan E A, Lakey J R T, Paty B W, et al. Successful islet transplantation continued insulin reserve provides long term glycemic control. Diabetes, 2002, 51(7): 2148-2157 [7] Banerjee M, Kanitkar M, Bhond R R. Approches towards endogeous pancreatic regeneration. Rev Diabet Stud, 2005, 2(3): 165-176 [8] Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 2001, 292(5520): 1389-1394 [9] Assady S, Maor G, Amit M, et al. Insulin production by human embryonic stem cells. Diabetes, 2001, 50(8): 1691-1697 [10] Hori Y, Rulifson I C, Tsai B C, et al. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci USA, 2002, 99 (25): 16105-16110 [11] Rajagopal J, Anderson W J, Kume S, et al. Insulin staining of ES cell progeny from insulin uptake. Science, 2003, 299 (5605): 363 [12] Hansson M, Tonning A, Frandsen U, et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes, 2004, 3(10): 2603-2609 [13] Vacap, Martin F, Vegara-Meseguer J M, et al. Induction of differentiation of embryonic stem cells into insulin-secreting cells by fetal soluble factors. Stem Cells, 2006, 24(2): 258-265 [14] D Amour K A, Bang A G, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol, 2006, 24(12): 1481-1483 [15] Fujikawa T, Oh S M, Pi L, et al. Teratoma formation leads to failure of treatment for Type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol, 2005, 166(6): 1781-1791 [16] Chen L B, Jiang X B, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet β cells. World J Gastroenterol, 2004, 10(20): 3016-3020 [17] Oh S H, Muzzonigro T M, Bae S H, et al. Adult bone marrow-derived cells transdifferentiating into insulin-producing cells for the treatment of type 1 diabetes. Lab Invest 2004, 84(5): 607-617 [18] Tang DQ, Cao L Z, Brant R, et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes, 2004, 53(7): 1721-1732 [19] Moriscot C, De Fraipont F, Richard M J, et al. Human bone marrow mesenchymal stem cells can express insulin and key

408 19 transcription factors of the endocrine pancreas developmental pathway upon genetic and /or mrcroenvironmental manipulation in vitro. Stem Cell, 2005, 23(4): 594-603 [20] Taneera J, Rosengren A, Renstrom E, et al. Failure of transplanted bone marrow cells to adopt a pancreatic -cell fate. Diabetes, 2006, 55(2): 290-296 [21],,,.., 2003, 5(5): 393-397 [22] Choi K S, Shin J S, Lee J J, et al. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun, 2005, 330(4): 1299-1305 [23] Petersen B E, Bowen W C, Patrene K D, et al. Bone marrow as a potential source of hepatic oval cells. Science, 1999, 284 (5417): 1168-1170 [24] Lu Y H, Wang Z W, Zhu M Y. Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably. Ann Clin Lab Sci, 2006, 36(2): 127-136 [25] Lee R H, Seo M J, Reger R L, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA, 2006, 103(46): 17438-17443 [26] Kim J H, Park S N, Suh H. Generation of insulin-producing human mesenchymal stem cells using recombinant adenoassociated virus.yonsei Med J, 2007, 48(1): 109-119 [27] Ianus A, Holz G G, Theise N D, et al. In vivo derivation of glucose -competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest, 2003, 111(6): 843-850 [28] Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol, 2003, 21(7): 763-770 [29] Ende N, Chen R F, Reddi A S. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun, 2004, 321(1): 168-171 [30] Ende N, Chen R F, Reddi A S. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun, 2004, 325(3): 665-669 [31] Sun B, Roh K H, Lee S R, et al. Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure. Biochem Biophys Res Commun, 2007, 354(4): 919-923 [32] Zhang L, Hong T P, Hu J, et al. Nestin-positive progenitor cells isolated from human fetal pancreas have phenotypic markers identical to mesenchymal stem cells. World J Gastroenterol, 2005, 11(19): 2906-2911 [33] Bouwens L. Transdifferentiation versus stem cell hypothesis for the regeneration of islet β-cells in the pancreas. Microsc Res Tech, 1998, 43(4), 332-336 [34] Cossel L. Intermediate cells in the pancreas and cell transformation. Zentralbl Allg Pathol, 1987, 6(133): 503-516 [35] Dudek R W, Lawrence I E, Hill R S, et al. Induction of islet cytodifferentiation by fetal mesenchyme in adult pancreatic ductal epithelium. Diabetes, 1991, 40(8): 1041-1048 [36] Koblas T, Zacharovova K, Berkova Z, et al. Isolation and Charaoterization of human CXCR4-positive pancreatic cells, Folia Biologica (Praha), 2007, 53(1): 13-22 [37] Yang L J, Li S W, Hatch H, et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA, 2002, 99 (12): 8078-8083 [38] Timper K, Seboek D, Eberhardt M, et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun, 2006, 341(4): 1135-1140 NF-κB 2007 7 16 The Journal of Cell Biology NF-κB UXT NFκB NF-κB (Enhancer) NF-κB NF-κB NF-κB NF-κB UXT NF-κB UXT NF-κB NF-κB UXT UXT NF-κB NF-κB http://www.sibs.ac.cn/